Abstract—This review summarizes the data on the radiosensitizing properties and cytotoxic activity of gold nanoparticles obtained in studies of experimental tumor models. Plausible mechanisms that underlie the observed effects are considered.
Similar content being viewed by others
REFERENCES
S. V. Kanaev, Prakt. Ned. 9, 1 (2008).
K. Bromma and D. B. Chithani, Nanomaterials (Basel) 10, 1671 (2020).
Y. Chen, J. Yang, S. Fu, and J. Wu, Int. J. Nanomedicine 15, 9407 (2020).
S. Siddique and C. L. Chow, Appl. Sci. 10, 3824 (2020).
W. Najahi-Missaui, R. D. Arnold, and B. Cummings, Int. J. Mol. Sci. 22, 385 (2021).
E. Porret, X. L. Guevel, and J. L. Coll, J. Mater. Chem. 13, 2216 (2020).
C. Gerosa, G. Crisponi, V. M. Nurchi, et al., Pharmaceuticals 13, 192 (2020).
J. F. Hainfeld, D. N. Slatkin, and H. M. Smilowitz, Phys. Med. Biol. 49, 309 (2004).
F. Geng, K. Song, J. Z. Xing, et al., Nanotechnology 22, 501 (2011).
M. Shi, B. Paquette, T. Thippayamentri, et al., Int. J. Nanomedicine 11, 5323 (2016).
S. Her, D. A. Jaffray, and C. Allen, Adv. Drug Delivery Rev. 109, 84 (2017).
S. Rosa, C. Connolly, G. Schettino, et al., Cancer Nanothechnol. 8, 2 (2017).
M. Y. Chang, Y. H. Shiau, C. J. Chang, et al., Cancer Sci. 99, 1479 (2008).
W. Roia, X. Zhang, L. Guo, et al., Nanothechnology 20, 5101 (2009).
S. Penninckx, A. C. Heuskin, C. Michiels, and S. Lucas, Cancer (Basel) 12, 2021 (2020).
X. Bai, Y. Wang, Z. Song, et al., Int. J. Mol. Sci. 21, 2480 (2020).
A. Vilchis-Juarez, G. Ferro-Flores, S. Santos-Cuevas, et al., Biomed. Nanotechnol. 10, 393 (2014).
S. Shrestha, L. N. Cooper, O. A. Andreev, et al., Jacobs J. Radiat. Oncol. 3, 026 (2016).
W. Cai, T. Cao, H. Hong, and J. Sun, Nanothenol. Sci. Appl. 1, 17 (2008).
Y. Tang, Y. Shen, L. Huang, et al., Environ. Toxicol. Pharmacol. 39, 871 (2015).
R. I. Beelbeco, H. Korideck, W. Ngwa, et al., Rad. Res. 178, 604 (2012).
W. Ngwa, R. Kumar, S. Sridhar, et al., Nanomedicine (London) 9, 1063 (2014).
E. Connor, J. Nwamuka, H. Gole, et al., Small 1, 325 (2005).
Y. Pan, S. Neuss, A. Leifert, et al., Small 3, 1941 (2007).
S. Jain, M. B. Bch, D. G. Hirst, and L. M. O`Sullivan, Br. J. Radiol. 85, 101 (2012).
A. M. Alkilany and C. J. Murphy, J. Nanopart. Res. 12, 2313 (2010).
V. N. Morozov, A. V. Belousov, V. I. Zverev, et al., Biophysics (Moscow) 65 (4), 533 (2020).
J. Zheng, D. J. Hunting, P. Ayotte, and L. Sanche, Radiat. Res. 169, 19 (2008).
C. J. Liu, C. Y. Wang, S. T. Cheng, et al., Phys. Med. Biol. 55, 931 (2010).
J. Scheumann, R. Berbeco, B. D. Chithrani, et al., Int. J. Radiat. Oncol. Biol. Phys. 94, 189 (2016).
F. Xiao, J. Zheng, P. Cloutier, et al., Nanothechnology 22, 465101 (2011).
K. T. Buttarworth, J. McMahon, F. J. Curreli, and K. M. Prise, Nanoscale 4, 4830 (2012).
S. Farahani, N. P. Alam, S. Haghgoo, et al., J. Biomed. Phys. Engl. 9, 199 (2019).
D. B. Chithrani, S. Jelveh, F. Jalali, et al., Radiat. Res. 173, 719 (2010).
L. E. Taggart, S. J. McMahon, K. T. Butterworth, et al., Nanotechnology 27, 215001 (2016).
P. Jawaid, M. Rehman, and Q. L. Zhao, Cell Death Discov. 6, 83 (2020).
S. Penninckx, A. C. Yeuskin, C. Michiels, and S. Lucas, Nanomedicine (London) 13, 2917 (2018).
K. Rieck, K. Bromma, W. Sung, et al., Br. J. Radiol. 92, 1100 (2019).
C. Wang, Y. Jiang, X. Li, and L. Hu, Breast Cancer 22, 413 (2015).
B. P. Coughlin, P. T. Lawrence, I. Lui, et al., J. Nanopart. Res. 22, 53 (2020).
N. Ma, P. Liu, N. He, et al., ACS Appl. Mater. Interfaces 9, 31526 (2017).
L. Cui, K. Tse, P. Zahedi, et al., Radiat. Res. 182, 475 (2014).
J. F. Hainfeld, H. M. Smilovitz, M. J. O`Connor, et al., Nanomedicine 8, 1601 (2013).
S. Jain, J. A. Coulter, A. R. Hounsell, et al., Int. J. Rad. Oncol. Biol. Phys. 79, 531 (2011).
S. Yook, Z. Cai, Y. Lu, et al., J. Nucl. Med. 57, 936 (2016).
Y. S. Chen, Y. C. Hung, I. Lian, and G. S. Huang, Nanoscale Res. Lett. 4, 858 (2009).
G. Maltzahn, J. H. Park, A. Agrawal, et al., Cancer Res. 69, 3892 (2009).
T. Kong, J. Zeng, X. Wang, et al., Small 4, 1537 (2008).
N. Ma, F. G. Wu, X. Zhang, et al., ACS Appl. Mater. Interfaces 9, 13037 (2017).
M. Enferadi, S. Y. Fu, J. H. Heng, et al., Int. J. Radiat. Biol. 94, 124 (2018).
C. Villiers, H. Freitas, R. Couderc, et al., J. Nanopart. Res. 12, 55 (2010).
S. Li, S. Bouchy, S. Penninckx, et al., Nanomedicine (London) 14, 317 (2019).
A. Popovtzer, A. Mizrachi, M. Moteli, et al., Nanoscale 8, 2678 (2016).
S. S. Mehrnia, B. Hashemi, S. J. Mowia, et al., Radiat. Oncol. 16, 33 (2021).
M. Kashin, Y. Kakei, S. Teraoka, et al., Biomed. Res. Int. 2020, 1281645 (2020).
N. H. Koonce, M. C. Quick, M. E. Hardel, et al., Int. J. Radiat. Oncol. Biol. Phys. 93, 588 (2015).
T. Wolfe, D. Chatteriee, J. Lee, et al., Nanomedicine 11, 1277 (2015).
X. D. Zhang, D. Wu, X. Shen, et al., Biomaterials 33, 6408 (2012).
V. Lin, S. McMahon, H. Paganetti, and J. Schuemann, Phys. Med. Biol. 60, 4149 (2015).
B. Janic, S. L. Brown, R. Nelf, et al., Cancer Biol. Ther. 22, 124 (2021).
S. Li, S. Penninckx, L. Karmani, et al., Nanotechnology 27, 455101 (2016).
N. Chen, W. Yang, Y. Bao, et al., RSC Adv. 5, 40514 (2015).
J. F. Hainfeld, F. A. Dilmanian, Z. Zhong, et al., Phys. Med. Biol. 55, 3045 (2010).
M. Mousavi, H. A. Nedali, S. Khoei, et al., Int. J. Radiol. Biol. 93, 214 (2017).
L. Taggart, S. I. McMahon, F. J. Currell, et al., Cancer Nanotechnol. 5, 5 (2014).
M. Zabihzadeh, M. Hoseini-Chahfarokhi, V. Bayati, et al., Nanomedicine 5, 111 (2018).
X. Zhang, J. Z. Xing, J. Chen, et al., Clin. Invest. Med. 31, 3 (2008).
X. D. Zhang, Z. Luo, J. C. Chen, et al., Adv. Mater. 26, 456 (2014).
X. D. Zhang, Z. Luo, J. Chen, et al., Sci. Rep. 5, 8669 (2015).
S. Liu, J. Piao, Y. Liu, et al., Nanomedicine (London) 13, 1371 (2018).
D. B. Korman, L. A. Ostrovskaya, and V. A. Kuz’min, Vopr. Onkol., No. 6, 78 (2018).
L. A. Ostrovskaya, D. B. Korman, N. V. Blyukhterova, et al., Ross. Bioterapevt. Zh. 19 (4), 74 (2020).
K. A. Abzaeva, L. V. Zhilitskaya, G. G. Belozerskaya, et al., Izv. Akad. Naik, Ser. Khim. 66 (12), 2314 (2017).
R. Ahmad, G. Schettino, G. Royle, et al., Part. Part. Syst. Charact. 37, 1900411 (2020).
K. T. Butterworth, J. A. Coulter, S. Jain, et al., Nanotechnology 21, 295101 (2010).
D. B. Korman, L. A. Ostrovskaya, and V. A. Kuz’min, Biophysics (Moscow) 64 (3), 431 (2019).
J. J. Li, D. Hartono, C. Orig, et al., Biomaterials 31, 5996 (2010).
Y. J. Gu, J. Cheng, C. C. Lin, et al., Toxicol. Appl. Pharmacol. 237, 196 (2009).
M. Musielak, A. Bos-Liedke, I. Piotrowski, et al., Int. J. Mol. Sci. 22, 16 (2021).
J. C. Dellavechia, B. T. Steiuer, M. L. Freitas, et al., J. Nanoparticle Res. 22, 133 (2020).
A. Chakraborty, A. Das, S. Raha, and A. Burui, J. Photochem. Photobiol. B: Biol. 203, 11778 (2020).
Y. Pan, A. Leifert, D. Ruan, et al., Small 5, 20657 (2009).
R. Liu, Y. Wang, Q. Yuan, et al., Chem. Commun. 50, 10687 (2014).
M. A. Mackey, F. Saira, M. A. Mahmond, and M. A. El-Sayed, Bioconijugate Chem. 24, 897 (2013).
B. Kang, M. A. Mackey, and M. A. El-Sayed, J. Amer. Chem. Soc. 132, 1517 (2010).
L. Ding, C. Yao, X. Yin, et al., Small 14, e1801451 (2018).
J. Bugno, M. J. Pollemann, and K. Sokolowski, Nanomedicine 21, 102059 (2019).
D. B. Chithrani, Mol. Membrane Biol. 27, 299 (2010).
M. Tsoli, H. Kuhn, W. Brandau, et al., Small 1, 841 (2005).
P. Navito, I. Prior, and M. Brust, ACS Nano 2, 1639 (2008).
J. Lee, D. Lilly, R. C. Doty, et al., Small 5, 1213 (2009).
W. S. Cho, M. Cho, J. Jeong, et al., Toxicol. Pharmacol. 245, 116 (2010).
W. H. De Yong, W. I. Haggens, P. I. Krystek, et al., Biomaterials 29, 1913 (2008).
C. Lasagna-Reeves, D. Gonzalez-Romero, M. A. Barria, et al., Biochem. Biophys. Res. Commun. 3939, 649 (2010).
M. A. Abdelhalini and B. M. Jarrar, J. Nanobiotechnol. 10, 5 (2012).
W. S. Cho, M. Cho, J. Jeong, et al., Toxicol. Appl. Pharmacol. 236, 16 (2009).
C. Rambanapasi, R. Zeevaart, H. Buntting, et al., Molecules 21, 763 (2016).
J. H. Lee, J. H. Sung, H. R. Ryn, et al., Arch. Toxicol. 92, 1393 (2018).
J. F. Hillyer and R. M. Albrecht, J. Pharm. Sci. 90, 1927 (2001).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare that they have no conflict of interest.
This article does not contain any studies involving humans or animals performed by any of the authors.
Additional information
Translated by V. Gulevich
Abbreviations: GNs, gold nanoparticles; BC, breast carcinoma; CC, colorectal cancer; PC, prostate cancer; HNSCC, head and neck squamous cell carcinoma; EPR, enhanced permeability and retention; DIF, dose increase factor; ROS, reactive oxygen species; EGFR, epidermal growth factor receptor; PGNs, pegylated gold nanoparticles.
Rights and permissions
About this article
Cite this article
Korman, D.B., Ostrovskaya, L.A., Bluhterova, N.V. et al. Gold Nanoparticles as Potential Radiosensitizing and Cytotoxic Agents. BIOPHYSICS 66, 1046–1058 (2021). https://doi.org/10.1134/S0006350921060063
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006350921060063